Atara Biotherapeutics Inc
ATRA
Market Cap$46.62M
Close$
$-2.33
131.4% downside
Current Fair Value
131.4% downsideOvervalued by 131.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $46.62 Million |
|---|---|
| Enterprise Value | $160.51 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-11.41 |
| Beta | 0.32 |
| Outstanding Shares | 10,690,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.23 |
|---|---|
| PEG | 0.29 |
| Price to Sales | 0.62 |
| Price to Book Ratio | -0.74 |
| Enterprise Value to Revenue | 1.24 |
| Enterprise Value to EBIT | -2.06 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.87 |
| Debt to Equity | -1.43 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Atara Biotherapeutics Inc
CEO: Pascal Touchon